MedPath
HSA Approval

FUROSEMIDE FRESENIUS KABI SOLUTION FOR INJECTION 20MG/2ML

SIN15131P

FUROSEMIDE FRESENIUS KABI SOLUTION FOR INJECTION 20MG/2ML

FUROSEMIDE FRESENIUS KABI SOLUTION FOR INJECTION 20MG/2ML

December 7, 2016

FRESENIUS KABI (SINGAPORE) PTE LTD

FRESENIUS KABI (SINGAPORE) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantFRESENIUS KABI (SINGAPORE) PTE LTD
Licence HolderFRESENIUS KABI (SINGAPORE) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, SOLUTION

INTRAVENOUS

Medical Information

C03CA01

furosemide

Manufacturer Information

FRESENIUS KABI (SINGAPORE) PTE LTD

Labesfal - Laboratorios Almiro, S.A. Fresenius Kabi Group

Active Ingredients

Furosemide

20mg/2ml

Furosemide

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

FUROSEMIDE FRESENIUS KABI SOLUTION FOR INJECTION 20MG/2ML - HSA Approval | MedPath